One of the weeks ahead we will..... get the result
Post# of 416
(Total Views: 940)
Posted On: 05/28/2017 11:20:46 AM
One of the weeks ahead we will..... get the results of the Q1-Q2 pre clinical.
It's going to be HUGE!!! In addition they filed a new patent during the process...
The president continues to accumulate shares on the open market daily!!!
The 21 patents and potential license fees are like gold in hand!!
This new paradigm in medicine is going to revolutionize treatment for an almost unlimited range of ailments, conditions, and diseases.
Opportunities like this are rare in ones life. This is a Ground floor opportunity.
Key here is the patience required. This could hit at any time. A buyout could happen any day!
It's going to be HUGE!!! In addition they filed a new patent during the process...
The president continues to accumulate shares on the open market daily!!!
The 21 patents and potential license fees are like gold in hand!!
This new paradigm in medicine is going to revolutionize treatment for an almost unlimited range of ailments, conditions, and diseases.
Opportunities like this are rare in ones life. This is a Ground floor opportunity.
Key here is the patience required. This could hit at any time. A buyout could happen any day!
(0)
(0)Endonovo Therapeutics, Inc. (ENDV) Stock Research Links
WORDS TO LIVE BY:
Never argue with stupid people, they will drag you down to their level and then beat you with experience.
Get .... PrivacyLok https://cyberidguard.com/
Try SafeVchat: https://cyberidguard.com/
My comments are only my opinion and are not to be used for investment advice.
Please conduct your own due diligence before choosing to buy or sell any stock.
Never argue with stupid people, they will drag you down to their level and then beat you with experience.
Get .... PrivacyLok https://cyberidguard.com/
Try SafeVchat: https://cyberidguard.com/
My comments are only my opinion and are not to be used for investment advice.
Please conduct your own due diligence before choosing to buy or sell any stock.
Scroll down for more posts ▼